TY - JOUR
T1 - Publisher Correction
T2 - Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like population (Acta Neuropathologica Communications, (2023), 11, 1, (50), 10.1186/s40478-023-01548-3)
AU - Regal, Joshua A.
AU - Guerra García, María E.
AU - Jain, Vaibhav
AU - Chandramohan, Vidyalakshmi
AU - Ashley, David M.
AU - Gregory, Simon G.
AU - Thompson, Eric M.
AU - López, Giselle Y.
AU - Reitman, Zachary J.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Following the publication of the original article [1], it was noted that due to a typesetting error Fig. 10 was incorrect. A part of Fig. 6 was incorrectly included also as Fig. 10. The correct figure is given hereafter. The publisher apologizes for the inconvenience caused. The incorrect Fig. 10 reads: (Figure presented.) Low grade glioma outcomes analysis. A, B Kaplan–Meier EFS (95% CI shaded, dotted line for median) for Bergthold et al. patients overall (A) and by resection status (B). C Kaplan–Meier EFS (95% CI shaded, dotted line for median) for Bergthold et al. patients by UCell score quartile for the gene signature of CD34, SOX2, CD99, and CTSC. D Forest plot of COXPH EFS HR for Bergthold et al. patients with continuous variables kept continuous. Includes HR for Z-score for the gene signature of CD34, SOX2, CD99, and CTSC. EFS = event-free survival, NR = none reported, GTR = gross total resection, NTR = near total resection, G/NTR = gross or near total resection, STR = subtotal resection, WT = wild-type. DA = diffuse astrocytoma, GG = ganglioglioma, ODG = oligodendroglioma, DNT = dysplastic neuroepithelial tumor, NOS or LGG = low-grade glioma, not otherwise specified. PA = pilocytic astrocytoma The correct Fig. 10 should read: (Figure presented.) Low grade glioma outcomes analysis. A, B Kaplan–Meier EFS (95% CI shaded, dotted line for median) for Bergthold et al. patients overall (A) and by resection status (B). C Kaplan–Meier EFS (95% CI shaded, dotted line for median) for Bergthold et al. patients by UCell score quartile for the gene signature of CD34, SOX2, CD99, and CTSC. D Forest plot of COXPH EFS HR for Bergthold et al. patients with continuous variables kept continuous. Includes HR for Z-score for the gene signature of CD34, SOX2, CD99, and CTSC. EFS = event-free survival, NR = none reported, GTR = gross total resection, NTR = near total resection, G/NTR = gross or near total resection, STR = subtotal resection, WT = wild-type. DA = diffuse astrocytoma, GG = ganglioglioma, ODG = oligodendroglioma, DNT = dysplastic neuroepithelial tumor, NOS or LGG = low-grade glioma, not otherwise specified. PA = pilocytic astrocytoma. The correct figure has been included in this correction, and the original article [1] has been corrected.
AB - Following the publication of the original article [1], it was noted that due to a typesetting error Fig. 10 was incorrect. A part of Fig. 6 was incorrectly included also as Fig. 10. The correct figure is given hereafter. The publisher apologizes for the inconvenience caused. The incorrect Fig. 10 reads: (Figure presented.) Low grade glioma outcomes analysis. A, B Kaplan–Meier EFS (95% CI shaded, dotted line for median) for Bergthold et al. patients overall (A) and by resection status (B). C Kaplan–Meier EFS (95% CI shaded, dotted line for median) for Bergthold et al. patients by UCell score quartile for the gene signature of CD34, SOX2, CD99, and CTSC. D Forest plot of COXPH EFS HR for Bergthold et al. patients with continuous variables kept continuous. Includes HR for Z-score for the gene signature of CD34, SOX2, CD99, and CTSC. EFS = event-free survival, NR = none reported, GTR = gross total resection, NTR = near total resection, G/NTR = gross or near total resection, STR = subtotal resection, WT = wild-type. DA = diffuse astrocytoma, GG = ganglioglioma, ODG = oligodendroglioma, DNT = dysplastic neuroepithelial tumor, NOS or LGG = low-grade glioma, not otherwise specified. PA = pilocytic astrocytoma The correct Fig. 10 should read: (Figure presented.) Low grade glioma outcomes analysis. A, B Kaplan–Meier EFS (95% CI shaded, dotted line for median) for Bergthold et al. patients overall (A) and by resection status (B). C Kaplan–Meier EFS (95% CI shaded, dotted line for median) for Bergthold et al. patients by UCell score quartile for the gene signature of CD34, SOX2, CD99, and CTSC. D Forest plot of COXPH EFS HR for Bergthold et al. patients with continuous variables kept continuous. Includes HR for Z-score for the gene signature of CD34, SOX2, CD99, and CTSC. EFS = event-free survival, NR = none reported, GTR = gross total resection, NTR = near total resection, G/NTR = gross or near total resection, STR = subtotal resection, WT = wild-type. DA = diffuse astrocytoma, GG = ganglioglioma, ODG = oligodendroglioma, DNT = dysplastic neuroepithelial tumor, NOS or LGG = low-grade glioma, not otherwise specified. PA = pilocytic astrocytoma. The correct figure has been included in this correction, and the original article [1] has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85197160577&partnerID=8YFLogxK
U2 - 10.1186/s40478-024-01788-x
DO - 10.1186/s40478-024-01788-x
M3 - Comment/debate
C2 - 38937835
AN - SCOPUS:85197160577
SN - 2051-5960
VL - 12
JO - Acta Neuropathologica Communications
JF - Acta Neuropathologica Communications
IS - 1
M1 - 107
ER -